Leading expert in multiple sclerosis and brain MRI, Dr. Paul M. Matthews, MD, explains his distinguished career in translational neuroscience. He holds prestigious academic and research leadership positions at Imperial College London. Dr. Matthews founded two world-renowned neuroimaging centers. His research focuses on inflammatory neurodegeneration and new therapy development. He has published over 400 scientific articles and received numerous accolades for his work.
More from Diagnostic Detectives Network
Translational Neuroscience and Advanced Brain Imaging in Multiple Sclerosis
Jump To Section
- Academic Leadership Roles
- Pioneering Neuroimaging Centers
- Medical Training and Neurology Background
- Research Focus on MS and Neurodegeneration
- Professional Recognition and Awards
- Full Transcript
Academic Leadership Roles
Dr. Paul M. Matthews, MD, holds several key academic leadership positions in neuroscience. He is the Chair of Translational Neuroscience and Therapeutics at Imperial College London. Dr. Matthews also serves as the Head of the Division of Brain Sciences within the college's Department of Medicine. His role as Professor of Clinical Neuroscience underscores his deep commitment to both research and patient care. Dr. Anton Titov, MD, highlights these significant roles during their discussion.
Pioneering Neuroimaging Centers
Dr. Paul M. Matthews, MD, is recognized for founding two internationally leading research imaging centers. He established and led the University of Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB). This center became a global hub for advanced brain MRI research. Dr. Matthews also founded the GlaxoSmithKline Clinical Imaging Center, bridging pharmaceutical research with cutting-edge imaging technology. His work as a Vice President at GlaxoSmithKline further demonstrates his impact on drug discovery and development.
Medical Training and Neurology Background
Dr. Paul M. Matthews, MD, received his elite medical training at prestigious institutions. He completed his medical education at the University of Oxford and Stanford University. Dr. Matthews then specialized in neurology with training at McGill University in Montreal, Canada. This strong foundation in clinical neurology informs his translational research approach. Dr. Anton Titov, MD, discusses this comprehensive training background in the interview.
Research Focus on MS and Neurodegeneration
Dr. Paul M. Matthews, MD, focuses his research on translational applications of clinical imaging. He has a specific interest in characterizing inflammatory neurodegeneration in multiple sclerosis. His work aims to develop new therapeutics for neurological diseases. Dr. Matthews has published over 400 scientific articles in top neuroscience journals. This extensive publication record reflects his major contributions to the understanding of brain disorders.
Professional Recognition and Awards
Dr. Paul M. Matthews, MD, has received significant recognition for his services to neuroscience. He was appointed Officer of the Order of the British Empire (OBE) in 2008. This honor acknowledges his exceptional contributions to the field. Dr. Matthews was elected to the UK Academy of Medical Sciences in 2014. He also holds visiting professorships at the University of Oxford, McGill University, and Nanyang Technological University. Dr. Anton Titov, MD, congratulates Dr. Matthews on these esteemed achievements.
Full Transcript
Dr. Anton Titov, MD: Hello! We are joined by Dr. Paul M. Matthews, who is in London. He is Chair of Translational Neuroscience and Therapeutics. He is Head of Division of Brain Sciences in the Department of Medicine and Professor of Clinical Neuroscience at Imperial College London. Professor Matthews is Chair of the MRC Neurosciences and Mental Health Board.
Dr. Paul M. Matthews is a Visiting Professor at the University of Oxford, McGill University, and Nanyang University's LKC School of Medicine. Dr. Matthews was also a founding Director of two internationally leading research imaging centers. He founded and led the University of Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, and GlaxoSmithKline's Clinical Imaging Center.
Dr. Paul M. Matthews was also a Vice President at GlaxoSmithKline's Discovery & Development Program. He did his medical training at the University of Oxford and Stanford University. He had training in neurology at McGill University in Montreal, Canada. He then returned to Oxford University to establish and lead the Center for Functional MRI of the Brain.
Dr. Paul M. Matthews focuses his research on translational applications of clinical imaging in neurosciences and the development of new therapeutics. He has focused specifically on characterization of inflammatory neurodegeneration in multiple sclerosis. Dr. Matthews has published over 400 scientific articles in neuroscience.
He is a recipient of many awards, including the Order of the British Empire, OBE, in 2008 for services to Neuroscience. Dr. Paul M. Matthews was elected to the Academy of Medical Sciences in 2014.
Dr. Anton Titov, MD: Hello and welcome!
Dr. Paul Matthews, MD: Thank you, it is nice to join you!